ARGINOX PHARMACEUTICALS, INC.

Company Information
Address ARGINOX PHARMACEUTICALS, INC.
120 CONSTITUTION DR, STE B
MENLO PARK, CA, 94025


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Therapy for Improving Vascular Function in Diabetes

    Amount: $128,203.00

    DESCRIPTION (provided by applicant): ArgiNOx is a recently-formed Wisconsin-based biotech startup that seeks to develop novel therapies for cardiovascular and inflammatory conditions resulting from in ...

    SBIRPhase I2004Department of Health and Human Services
  2. Use of NOS inhibitor to expand hematopoietic stem cells

    Amount: $192,938.00

    DESCRIPTION (provided by applicant): Hematopoietic cell-supported therapy is employed for a broad spectrum of malignancies and hematological disease. However, the approach is limited by the availabili ...

    SBIRPhase I2004Department of Health and Human Services
  3. NOS Inhibitor Therapy for Cardiogenic Shock

    Amount: $271,044.00

    DESCRIPTION (provided by applicant): This is a Fast-track Phase I application from ArgiNOx Inc. to develop a novel pharmacotherapy that may save lives of tens of thousands of patients that develop car ...

    SBIRPhase I2003Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government